Milk or plant drinks? study tests which builds better bones with exercise
NCT ID NCT06946316
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares drinking dairy milk, pea-based, or almond-based beverages after resistance training sessions for 12 months. It includes 150 postmenopausal women and men aged 50 and older. The goal is to see which drink best improves bone density and strength, helping prevent osteoporosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dairy milk, pea-based beverage, almond-based beverage
- What this could lead to
- If it works, this could show which type of milk or plant drink best supports bone strength when combined with exercise, helping prevent fractures.
- What could go wrong
- This is an early-stage study with 150 people, so results may not apply to everyone. Differences between drinks may be small, and bone changes take time to show.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
College of Kinesiology University of Saskatchewan
RECRUITINGSaskatoon, Saskatchewan, S7K 2X2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can discarded bone reveal the secrets to stronger bones?
- Could a common diabetes drug weaken your bones?
- A tastier calcium chew might boost bone Health—But does it work?
- Exercise program aims to steady the stance of osteoporosis patients
- Can a Bone-Strengthening infusion given right after hip surgery prevent a second break?
- Can a single dose of zoledronic acid safely treat bone loss in dialysis patients?